[Elsevier/Sciencedirect] Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

perfecto 发表于 昨天 23:19 | 显示全部楼层 |阅读模式
此帖将于 2026-08-22 23:14 自动关闭
悬赏30积分


DOI号: 10.1016/S1470-2045(24)00318-8

文献链接:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00318-8/abstract

文献作者:Prof Jean-Yves Blay, MD[url=]a[/url],[url=]b[/url],[url=]c[/url],[url=]*[/url] Send email to jean-yves.blay@lyon.unicancer.fr ∙ Quentin Devin, MSc[url=]a[/url],[url=]b[/url],[url=]c[/url],[url=]*[/url] ∙ Prof Florence Duffaud, MD[url=]d[/url] ∙ Maud Toulmonde, MD[url=]e[/url] ∙ Nelly Firmin, MD[url=]f[/url] ∙ Olivier Collard, MD[url=]a[/url],[url=]b[/url],[url=]c[/url],[url=]g[/url] ∙ Emmanuelle Bompas, MD[url=]h[/url] ∙ Benjamin Verret, MD[url=]g[/url],[url=]i[/url] ∙ Prof Isabelle Ray-Coquard, MD[url=]a[/url],[url=]b[/url],[url=]c[/url] ∙ Prof Sebastien Salas, MD[url=]d[/url] ∙ Clemence Henon, MD[url=]g[/url],[url=]i[/url] ∙ Charles Honoré, MD[url=]g[/url] ∙ Mehdi Brahmi, MD[url=]a[/url],[url=]b[/url],[url=]c[/url] ∙ Armelle Dufresne, MD[url=]a[/url],[url=]b[/url],[url=]c[/url] ∙ Marc Pracht, MD[url=]j[/url] ∙ Alice Hervieu, MD[url=]k[/url] ∙ Prof Nicolas Penel, MD[url=]l[/url] ∙ Prof Francois Bertucci, MD[url=]m[/url] ∙ Maria Rios, MD[url=]n[/url] ∙ Esma Saada-Bouzid, MD[url=]o[/url] ∙ Pauline Soibinet, MD[url=]p[/url] ∙ David Perol, MD[url=]a[/url],[url=]c[/url],[url=]q[/url] ∙ Sylvie Chabaud, PhD[url=]a[/url],[url=]c[/url],[url=]q[/url] ∙ Prof Antoine Italiano, MD[url=]e[/url] ∙ Axel Le Cesne, MD[url=]i[/url]

备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

VIP会员
  • 发布

  • 回复

  • 积分

    580

返回列表